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ABSTRACT
Background: Marjolin's ulcers though thought to be 
rare have been reported to have a higher incidence in 
sub-Saharan Africa. These tumours typically run an 
aggressive course with a poor prognosis. Late 
presentation has been reported to be typical of  these 
cancers and some of  the reasons adduced for this, are 
difficulties in both clinical and pathological diagnosis. 
This review therefore aims at enlightening the medical 
community on Marjolin's ulcers with a view to 
improving early recognition, treatment and outcome. 
Method: Literatures on marjolin's ulcers were sourced 
from available journals and internet based searches 
using Pubmed, Medline and Google search.
Results: The incidence of  Marjolin's ulcers appears 
higher in developing countries. First recognized in the 
first century AD, a lot is yet to be understood about the 
evolution of  these cancers. Late presentation still 
remains a feature of  this pathology even in recent times. 
Prognosis improves drastically with early recognition 
and treatment.
Conclusion: The key to improving outcome in 
Marjolin's ulcers is early recognition and adequate 
treatment.
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5The term 'Marjolin's  ulcer' was first used by Da Costa in 1903,   
in describing tumours arising from simple leg ulcers. This was 
however restrictive in nature considering there were then 
numerous reports of  these carcinomas arising from other 
lesions besides chronic leg ulcers. Other authors suggested 
4broader terms like cicartrical and scar cancers.
In modern parlance, the term “marjolin ulcer” refers to 
6carcinomas arising from chronically inflamed, or scarred skin 
EPIDEMIOLOGY
The true incidence of  marjolin ulcers is largely unknown. It is 
however thought to be rare. Earlier reports of  incidences of  1.2 
to 2 percent of  skin cancers were restricted to carcinomas 
1,7arising from burn scars.  The incidence however shows 
regional differences due to sociocultural and economic 
influences. Incidences of  up to 6.8% have been reported 
amongst the kashmiri Indians, where the cultural practice of  
wearing the “Kangri,” an earthen oven underneath a flowing 
gown predisposes to repeated burn injuries and subsequent 
development of  marjolin ulcers popularly called “Kangri 
8ulcers.”   Similar ulcers are also reported in some parts of  
Japan where the practice of  wearing tin ovens around the 
abdominal region underneath the garment results in the 
“Kairo burn cancer” In North-western China, malignant 
ulcers on the buttocks known as the Kang Ulcer similarly result 
from the practice of  warming the bed with external heat. 
“Erythema ab Igne,” a chronic thermal dermatitis commonly 
seen in stockers and those who regularly warm themselves by 
9,10
open fires also occasionally undergoes malignant change. 
In sub-Saharan Africa, the incidence of  these ulcers is also 
11reported to be higher than the generally reported incidence.  
Up to 63% of  squamous cell carcinomas in some series arose 
12 from chronically irritated or scarred skin. The relative high 
prevalence of  preceding conditions for the development of  
marjolin's ulcers  such as chronic leg ulcers and poorly 
managed burns; amongst Sub-Saharan communities, may be 
responsible.
Marjolin ulcers have been reported in every age group, but 
occur predominantly in middle age, with a reported average 
9,13age of  onset of  53 to 59 years  The age of  onset is however 
thought to be lower in less developed societies. Sisrat and 
8Shrikhande   reported an age of  onset of  44years in India in the 
late 1960s. Asuquo et al reported  44.1 years as the average age 
of  their patients presenting with marjolin's ulcers in south 
11eastern Nigeria. Nthumba  recently reported an average age 
of  onset of  between 36 and 42 years in Sub Saharan Africa. 
These averages may not however be truly representative, as a 
number of  variables such as aetiologic agent, and age at time of  
onset of  the predisposing condition, are known to influence the 
age of  onset of  these cancers: The latent period, that is the time 
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HISTORICAL PERSPECTIVE
It was Celcius who first observed malignant transformation in 
1burn scars in AD 100.   About 1,700 years later, precisely in 
1828, Jean Nicholas Marjolin, a French surgeon, published an 
article in the French Dictionaire de Medicine on a series of  
2simple leg ulcers which showed warty changes.  Described as 
'Ulcer canchroides', he did not at the time recognize the 
malignant nature of  these transformations. A more 
comprehensive description of  these lesions was to be made a 
3couple of  years later by Dupuytren.   Later reports of  these 
transformations by Byron and Smith in 1844 and 1850 
4respectively were to confirm these conditions as carcinomas.   
They described cancers arising in burn scars, scars from 
flogging as well as other forms of  trauma.
from onset of  the predisposing condition, to the development 
of  cancer, has been shown to be inversely proportional to the 
11,14-16age of  onset of  the predisposing chronic condition.  The 
average ages reported will therefore depend largely on the 
make up of  the study population.
Most reports show a male preponderance, with ratios of  2 to 
8,9,13,14,17 3:1 reported. Reasons for this may range from genetic 
differences, to a simple male bias for the predisposing 
conditions.
Marjolin ulcers show no racial predilection. Cultural and 
socioeconomic factors as earlier highlighted however influence 
the distribution of  the disease.
PATHOGENESIS
Ewing formulated a set of  criteria to establish the relationship 
9between trauma and the development of  cancer.  These were 
equally adapted to the development of  cancers in burn scars by 
1Treves and Pack.  These criteria are relevant even in modern 
times, as a relationship of  cancer to preceding trauma or a pre-
existing chronic condition must be established to make a 
diagnosis of  Marjolin's ulcer. These criteria are as follows:- 
· The cancer must arise within the boundaries of  the scar or 
wound.
· Incontrovertible evidence of  trauma or the pre-existing 
ulcer as evidenced by the wound or scar.
· The absence of  any precursory or similar neoplasm on the 
site of  the trauma/wound prior to the development of  the 
cancer
· The histologic variety of  the cancer must be compatible 
with the tissues found in the site of  the trauma or 
scar/wound
· The interval time between the trauma/ulcer and the onset 
of  the cancer must be appropriate. A period of  one month 
has been proposed as the minimum acceptable time 
18between the trauma/ulcer and the onset of  the cancer.
Numerous causative agents in the development of  marjolin 
ulcers have been reported. These include Burn and non-burn 
traumas, osteomyelitis sinuses, pressure sores, urinary fistulas, 
pilonidal sinuses, gumata, radiation scars, and scars from 
4flogging, etc . The process of  evolution of  this scarred or 
chronically irritated skin into a malignant tumour is not clearly 
understood. Several theories have been propounded, but none 
fully explains all aspects of  this evolution. Some of  these 
theories include:-
Virchows theory of  chronic irritation. This theory explains that 
with chronic irritation and repeated tissue injury, attempts at 
healing become increasingly difficult and the regenerated 
epithelium less stable. This less stable epithelium under 
persistent stimulus for regeneration, eventually loses contact 
9inhibition, and undergoes malignant change.
Friedwald and Rouse proposed the co-carcinogenic theory 
which proposes an initiator phase and a promoter phase in the 
development of  marjolin ulcers. An area previously exposed to 
a carcinogenic stimulus known as the “initiator”, developes 
dormant neoplastic cells which when acted upon by a co-
carcinogen or“promoter” are activated, and evolve into a 
19cancer.  Either of  these acting alone may not be  sufficient in 
itself  to bring about the development of  a cancer. By this theory, 
a burn may act as an “initiator,” while actinic radiation or some 
other carcinogenic stimulus acting on the burn scar acts as the 
“promoter.” Saffioti and Shubik showed the potentiating effect 
of  cotton oil on the development of  carcinoma in burn sites on 
9mice.   Arons experimentally showed changes ranging from 
acanthosis to epidermoid carcinoma in tissues of  rats exposed 
9,19to repeated trauma;  thus implicating trauma as a 
carcinogenic agent. These give support to the co-carcinogenic 
theory.
1Treves and Pack  proposed the toxin theory. They suggest that 
as a result of  tissue damage, toxins are released which result in a 
nutritional deficiency at the cellular level. This compromises 
the ability of  the cells to effect tissue repairs following 
carcinogenic insults with attendant accumulation of  mutated 
DNA and subsequent malignant change.
Ribet's theory of  epithelial element implantation, suggests that 
epithelial elements implanted into the dermis following trauma, 
undergo a disordered regenerative process leading to 
11carcinomatous change.
A number of  researchers, support the immunologically 
privillaged site theory. Castillo and Goldsmith suggested that 
the poor lymphatic f low in scar tissue, impairs 
immunosurveillance, making it difficult for the body to mount 
an effective antigen-antibody response to proto-oncogens or 
tumour within the scar. " Futrell and Myers later suggested that 
this apparent shielding allowed the tumour to "escape" early 
20recognition by the normal host. 
The hereditary theories were proposed after p53 and Fas gene 
21,22mutations were found in patients with Marjolin's ulcers . 
The environmental and genetic interaction theory seeks to 
23explain the evolution of  acute Marjolin's ulcers,  suggesting 
that genetic differences make the individual more succeptible 
to the environmental insult, resulting in a short latent period. 
Studies have also shown patients with Marjolin ulcers have a 
decreased T-cell count, suggesting that immunosuppression is 
20a contributory factor.
None of  the theories so far proposed in itself  fully explains the 
evolution of  Marjolin's ulcers. At best they only explain aspects 
of  the process of  malignant transformation leading some 
authors to propose the multifactorial theory which proposes 
that a combination of  the above theories will best explain the 
24process of  evolution of  Marjolin's ulcers.
CLINICAL FEATURES
Characteristically, there is a time lag, or latent period between 
the primary pathology and the development of  carcinoma. 
This time lag is variable, ranging from a few weeks to several 
years. A time lag of  up to 70years has been reported in some 
4series  The shortest reported time lag has been 4 weeks, by 
25,26Mcleod and Stauffer.   The challenge in these cases with ultra 
short latent periods, is to prove the absence of  cancer in the 
tissues prior to development of  the observed malignant 
transformation. Indeed some have argued that these Marjolin 
ulcers with ultra short latent periods may actually have arisen 
17from skin which previously had premalignant changes . In any 
case, two distinct types of  marjolin ulcers are described; Acute 
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marjolin ulcers with a lag phase of  less than one year, and 
chronic marjolin ulcers with a lag phase longer than a year. The 
former which is quite rare is seen more often following burn 
1injuries in the older age groups.  This as pointed out by 
4Nancarrow  may suggest that the skin is less able to withstand 
trauma and indeed carcinogenic insults, as it ages.
In general the average latent period for marjolin's ulcer has 
9been reported to be between 20 and 40 years.  Shorter averages 
11,12are however reported in sub-Saharan Africa.
The commenest region of  the body involved are the lower limbs. 
Average figures of  40% for the lower extremities, 30%  for the 
head and neck region,  20% for the upper extremities, and10%  
20,28for the trunk are generally accepted.   The predominance of  
lower limb involvement in cicartrical cancers as opposed to the 
overwhelming head and neck predominance in spontaneous 
epidermoid carcinomas suggests the less significant role of  
actinic radiation in the aetiopathogenesis of  marjolin's ulcers 
as opposed to spontaneous epidermoid carcinomas. Marjolin 
ulcers are also commoner in scars over flexion creases and 
junctions of  mobile and non mobile areas. These scars are 
exposed to recurrent trauma and therefore more likely to be 
unstable. Also, thick, firm, hypopigmented scars, as well as 
scars from deep burns allowed to heal slowly without skin 
grafting, show less stability and therefore have a greater 
1,8,29,30tendency towards malignant change.
1 Treves and pack  describe two clinical types of  marjolin ulcers
· The flat indurated, infilterative, ulcerative marjolin ulcer.
· The less frequent exophytic papillary form.
The former is commoner, with a poorer prognosis. Malignant 
changes in scars/ chronic ulcers are often insidious and 
heralded by pain. There may also be a change in the nature of  
discharge which often becomes offensive and sometimes 
hemorrhagic. The extension of  the ulcer is often slow in the 
9early stages 
The malignant change often begins at the edge which may 
show some warty change with elevation. Occasionally there is 
the appearance of  a mass within the scar or ulcer. The base of  
the ulcer becomes increasingly indurated with a granular, often 
necrotic floor with blood clots. Healing may occur in some 
areas where sloughing has occurred thus presenting a 
9,20,31deceptively innocuous appearance.  It is also important to 
note that all the signs of  malignant transformation must not 
necessarily be present to draw a suspiscion of  Marjolin's ulcer. 
Nthumba in presenting his series on Marjolin's ulcer 
developing from pressure sores, noted that these ulcers 
commonly had a benign appearance of  both the ulcer edges 
and the bases, and except for a foul smell, showed none of  the 
32classical signs of  malignant transformation.  This 
occasionally makes clinical diagnosis difficult. The occasional 
difficulty in making a clinical diagnosis, as well as confounding 
histopathological features are some of  the reasons cited by 
37 Vanessa et al as being responsible for the observed late 
presentation commonly seen in patients with Marjolin's 
33-38ulcers.
With time these tumours invade the deeper tissues such as 
muscle, bone and other deeper structures. Fig. 1. Patients 
occasionally present with pathological fractures.
Marjolin ulcers in the early stages spread mainly by direct 
tissue invasion with metastasis occurring relatively late. 
Lymphatic spread occurs in the late stages especially when the 
tumour has gone beyond the margin of  the scar. This may be 
explained by the poor lymphatic flow in scar tissue, a feature 
which also confers some protection from immunological 
recognition on the early stages of  Marjolin's  ulcers as 
7suggested by castilo and goldsmith.  The presence of  regional 
lymph node metastasis is considered the most important 
9 prognostic factor. Distant metastases are uncommon.
DIAGNOSIS
The main stay of  dignosis is histological. Tissue biopsy should 
be taken from the suspiscious areas of  the edge as well as the 
1central area.  Malignant transformation usually starts at a 
9margin with gradual progression.  The clinician must therefore 
recognize areas of  suspiscious change, to reduce the chances of  
a false negative biopsy results. Considering the multifocal 
nature of  marjolin ulcers, some authors have suggested an 
excision biopsy of  the entire scar/ulcer where possible, to 
39reduce the chances of  a false negative.  Indeed cases where 
multiple focal biopsies turned out negative but complete 
excision revealed presence of  carcinomatous change have been 
40reported.
The commonest histological variety seen in marjolin's ulcer is 
4,9,11squamous cell carcinoma.  Other histological varieties like 
basal cell carcinomas, malignant melanomas, fibrosarcomas, 
4,5,14,37liposarcomas, have been reported.  Occasionally, more 
than one histologic variant may be seen within the same scar. 
Presence of  a mix of  basal and squamous cell cancer often 
9described as basosquamous, have been reported. Novick et al  
also reported a combination of  squamous cell carcinoma, and 
melanoma within the same scar. This probably implies a 
common aetiopathogenesis for the variety of  histological types 
of  cancers seen in marjolin's ulcers.
A common confounding histological  f inding is  
pseudoepitheliomatous hyperplasia commonly seen in chronic 
ulcers. This shows irregular invasion of  the dermis, but unlike 
in squamous cell carcinoma, the squamous cells are usually 
well differentiated with leukocytic invasion of  the proliferating 
epithelium which is usually limited by a definite basement 
membrane. It is however important to note that malignant 
change may occur in a field of  pseudoepitheliomatous 
hyperplasia hence the need for Multiple biopsies from different 
9,41sites.
Radiological imaging techniques such as CT scan, MRI and 
plain radiographs are useful in assessing involvement of  deeper 
tissues. The typical imaging features of  Marjolin's ulcer as 
highlighted by Smith J et al are bone destruction, soft tissue 
6mass and periosteal reaction . CT is however more sensitive 
than plain radiographs in detecting skeletal involvement, while 
MRI better delineates soft tissue involvement.
TREATMENT
Surgery remains the main stay of  treatment for Marjolin's ulcer. 
Wide surgical excision with margins of  up to 2 to 4 cm have 
12,20,42been suggested by various authors 
A surgical margin of  2 cm is however generally 
9,23recommended.  Some authors have recommended a wider 
43margin of  2.5cm for recurrent tumours.   In view of  the 
multifocal nature of  marjolin's ulcers however, the suggestion 
by Nancarrow of  excising the entire scar tissue where possible 
and not just the area of  malignant degeneration appears logical. 
Cases of  multiple tumours arising within the same scar have 
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39,40been reported.,  This is supported by the field of  change 
theory of  carcinogenesis by Willis, where the scar tissue may be 
considered as that field of  change. The fact that local 
reccurrences often occur within the residual scar supports this 
line of  management. 
Defects following resection should be skin grafted except 
where the bed may not be suitable for a skin graft, then a flap 
9may be used. Novick et al  suggests that a minimum of  a 12 
month interval be given between tumour extirpation, and 
definitive reconstruction to avoid obscuring local recurrences. 
This is indeed advisable considering the high recurrence rates 
associated with marjolin's ulcers.
Amputation is indicated when deep invasion makes local 
excision impossible, when there is bone or joint involvement, or 
when excision would severely impair function and encumber 
9,44treatment.
45Regional metastases occur  in 2 to 6% of  cases,  therefore the 
regional nodes should be thoroughly assessed in a patient 
presenting with marjolin's ulcers.
Lymph node dissection is generally advised in the presence of  
clinically palpable nodes and not as a prophylactic measure as 
12,46- 48shown in numerous studies.
Some investigators however suggest prophylactic node 
dissection(PND), based on the low salvage rate for regional 
9,47node metastases.  Late presentation may be a reason for this 
low salvage rate. In difficult terrains, where access to medical 
care is greatly limited, PND will probably do more good than 
harm.  
Marjolin ulcers show poor response to radiotherapy as a result 
42of  their relative poor vascularity, due to extensive fibrosis.   
Radiotherapy has however found some use in palliation of  
55inoperable primary or recurrent tumours  
The relative poor vascularity of  these cancers may also explain 
their poor response to systemic chemotherapy. Intra-arterial 
perfusion with methotrexate was reported by Novick et al as a 
9useful adjunct to surgery.
PREVENTION
Unstable scars and scars arising from burn wounds allowed to 
heal slowly have been shown to run a higher risk of  malignant 
1,4,9,14change.  Deep burn wounds should be primarily grafted 
where possible, and unstable scars excised and grafted. Poor 
scars with a high risk of  instability such as thick, 
hypopigmented inelastic scars across joints or mobile areas 
should be excised and replaced with supple tissue. It is 
important that such scar excisions should be adequate in depth 
4as it is thought that dermal induction does occur.  
Scars on the scalp should be excised where possible, or 
protected from actinic injury. Moreso in regions with 
significant sunshine, people with significant scaring on their 
scalp should be adviced to use wigs or protective clothing over 
their scalp when out in the open during periods of  peak 
sunshine. Repeated exposure to corrosive chemicals used in 
perming the hair may not be adviseable in such patients.
PROGNOSIS
Marjolin's ulcers are generally thought to have a poor 
4,9,50-52prognosis. . Squamous cell carcinomas arising from scars 
are 10 times more likely to metastasise than those arising from 
15,16actinic damage.  Determinants of  poor prognosis include 
short latency period, lower limb involvement as opposed to 
involvement of  the upper limb, trunk and head and neck, as 
well as tumour size. Tumours less than 2cm in diameter are 
thought to have a better prognosis than those greater than 2cm 
in diameter. The less well differentiated tumours also carry a 
poorer prognosis. Deeper penetrating tumours as measured by 
depth of  dermal invasion and vertical tumour thickness carry a 
worse prognosis. Recurrent tumours, and tumours with scanty 
peritumoural T lymphocyte infilteration also run a more 
aggressive course. The scanty peritumoural T lymphocyte 
infilteration signifies a poor host immune response.  The 
primary lesion undergoing malignant change also influences 
prognosis; Tumours arising from pressure sores run a more 
aggressive course than those arising from post burn scars or 
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Fig.1: Advanced Marjolin's ulcer of the scalp showing 
invation of the skull.
 
9,43,53,54chronic ulcers. . The most important prognostic factor 
however is the presence of  lymph node metastasis and this has 
9,45been shown to correlate with outcome.
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